Dopamine D1-receptors modulate lateral inhibition between principal cells of the nucleus accumbens.
Taverna
Stefano
S
Department of Anatomy, Vrije Universiteit Medical Center, Graduate School Neurosciences Amsterdam, The Netherlands.
Canciani
Barbara
B
Pennartz
Cyriel M A
CM
D015647:2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / Q000494:pharmacology; D000818:Animals; D001552:Benzazepines / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D007839:Functional Laterality / Q000502:physiology*; D008239:Lysine / Q000031:analogs & derivatives* / Q000378:metabolism; D008297:Male; D009433:Neural Inhibition / Q000187:drug effects / Q000502:physiology*; D009474:Neurons / Q000145:classification / Q000187:drug effects / Q000502:physiology*; D009714:Nucleus Accumbens / Q000166:cytology*; D051381:Rats; D017208:Rats, Wistar; D017447:Receptors, Dopamine D1 / Q000819:agonists / Q000037:antagonists & inhibitors / Q000502:physiology*; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology
D001552:Benzazepines; D017447:Receptors, Dopamine D1; D015647:2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; C013411:biocytin; D008239:Lysine; D004298:Dopamine